Logo image of PBPB

POTBELLY CORP (PBPB) Stock Fundamental Analysis

USA - NASDAQ:PBPB - US73754Y1001 - Common Stock

17.03 USD
0 (0%)
Last: 9/26/2025, 8:21:51 PM
17.02 USD
-0.01 (-0.06%)
After Hours: 9/26/2025, 8:21:51 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PBPB. PBPB was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. PBPB has an average financial health and profitability rating. PBPB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year PBPB was profitable.
PBPB had a positive operating cash flow in the past year.
In multiple years PBPB reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: PBPB reported negative operating cash flow in multiple years.
PBPB Yearly Net Income VS EBIT VS OCF VS FCFPBPB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

PBPB has a Return On Assets (4.06%) which is in line with its industry peers.
PBPB has a Return On Equity of 17.56%. This is in the better half of the industry: PBPB outperforms 76.30% of its industry peers.
PBPB has a Return On Invested Capital (6.48%) which is in line with its industry peers.
PBPB had an Average Return On Invested Capital over the past 3 years of 4.13%. This is significantly below the industry average of 15.67%.
The 3 year average ROIC (4.13%) for PBPB is below the current ROIC(6.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.06%
ROE 17.56%
ROIC 6.48%
ROA(3y)6.36%
ROA(5y)-2.68%
ROE(3y)66.47%
ROE(5y)N/A
ROIC(3y)4.13%
ROIC(5y)N/A
PBPB Yearly ROA, ROE, ROICPBPB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

1.3 Margins

The Profit Margin of PBPB (2.30%) is comparable to the rest of the industry.
The Operating Margin of PBPB (3.08%) is worse than 70.37% of its industry peers.
With an excellent Gross Margin value of 74.63%, PBPB belongs to the best of the industry, outperforming 89.63% of the companies in the same industry.
PBPB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.08%
PM (TTM) 2.3%
GM 74.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.78%
GM growth 5Y0.13%
PBPB Yearly Profit, Operating, Gross MarginsPBPB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PBPB is destroying value.
Compared to 1 year ago, PBPB has more shares outstanding
PBPB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PBPB has been reduced compared to a year ago.
PBPB Yearly Shares OutstandingPBPB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PBPB Yearly Total Debt VS Total AssetsPBPB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

PBPB has an Altman-Z score of 1.77. This is a bad value and indicates that PBPB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.77, PBPB is in line with its industry, outperforming 51.85% of the companies in the same industry.
There is no outstanding debt for PBPB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.77
ROIC/WACC0.73
WACC8.89%
PBPB Yearly LT Debt VS Equity VS FCFPBPB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.50 indicates that PBPB may have some problems paying its short term obligations.
PBPB has a worse Current ratio (0.50) than 74.07% of its industry peers.
PBPB has a Quick Ratio of 0.50. This is a bad value and indicates that PBPB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.45, PBPB is doing worse than 74.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.45
PBPB Yearly Current Assets VS Current LiabilitesPBPB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.00% over the past year.
PBPB shows a decrease in Revenue. In the last year, the revenue decreased by -1.73%.
PBPB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.46% yearly.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y6.77%
Revenue growth 5Y2.46%
Sales Q2Q%3.35%

3.2 Future

The Earnings Per Share is expected to grow by 25.40% on average over the next years. This is a very strong growth
Based on estimates for the next years, PBPB will show a small growth in Revenue. The Revenue will grow by 3.96% on average per year.
EPS Next Y-13.3%
EPS Next 2Y11.02%
EPS Next 3Y25.4%
EPS Next 5YN/A
Revenue Next Year3.23%
Revenue Next 2Y3.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PBPB Yearly Revenue VS EstimatesPBPB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PBPB Yearly EPS VS EstimatesPBPB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 56.77 indicates a quite expensive valuation of PBPB.
PBPB's Price/Earnings is on the same level as the industry average.
PBPB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.32.
Based on the Price/Forward Earnings ratio of 46.06, the valuation of PBPB can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as PBPB.
When comparing the Price/Forward Earnings ratio of PBPB to the average of the S&P500 Index (22.89), we can say PBPB is valued expensively.
Industry RankSector Rank
PE 56.77
Fwd PE 46.06
PBPB Price Earnings VS Forward Price EarningsPBPB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as PBPB.
PBPB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 30.74
EV/EBITDA 17.35
PBPB Per share dataPBPB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as PBPB's earnings are expected to grow with 25.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.02%
EPS Next 3Y25.4%

0

5. Dividend

5.1 Amount

PBPB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POTBELLY CORP

NASDAQ:PBPB (9/26/2025, 8:21:51 PM)

After market: 17.02 -0.01 (-0.06%)

17.03

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05
Inst Owners82.89%
Inst Owner Change5.24%
Ins Owners10.07%
Ins Owner Change7.51%
Market Cap515.16M
Analysts80
Price Target17.46 (2.52%)
Short Float %4.65%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)49.02%
Min EPS beat(2)-1.96%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)69.67%
Min EPS beat(4)-1.96%
Max EPS beat(4)100%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-0.87%
Max Revenue beat(2)-0.45%
Revenue beat(4)0
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-1.75%
Max Revenue beat(4)-0.3%
Revenue beat(8)0
Avg Revenue beat(8)-1.32%
Revenue beat(12)0
Avg Revenue beat(12)-1.6%
Revenue beat(16)2
Avg Revenue beat(16)-1.06%
PT rev (1m)-3.09%
PT rev (3m)0.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.6%
EPS NY rev (1m)-7.83%
EPS NY rev (3m)-4.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.41%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 56.77
Fwd PE 46.06
P/S 1.1
P/FCF 30.74
P/OCF 13.49
P/B 8.4
P/tB 9.22
EV/EBITDA 17.35
EPS(TTM)0.3
EY1.76%
EPS(NY)0.37
Fwd EY2.17%
FCF(TTM)0.55
FCFY3.25%
OCF(TTM)1.26
OCFY7.41%
SpS15.51
BVpS2.03
TBVpS1.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.06%
ROE 17.56%
ROCE 7.54%
ROIC 6.48%
ROICexc 7.08%
ROICexgc 7.31%
OM 3.08%
PM (TTM) 2.3%
GM 74.63%
FCFM 3.57%
ROA(3y)6.36%
ROA(5y)-2.68%
ROE(3y)66.47%
ROE(5y)N/A
ROIC(3y)4.13%
ROIC(5y)N/A
ROICexc(3y)4.69%
ROICexc(5y)N/A
ROICexgc(3y)4.85%
ROICexgc(5y)N/A
ROCE(3y)4.81%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.78%
GM growth 5Y0.13%
F-Score7
Asset Turnover1.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 149.89%
Cap/Sales 4.57%
Interest Coverage 33.55
Cash Conversion 132.79%
Profit Quality 155.54%
Current Ratio 0.5
Quick Ratio 0.45
Altman-Z 1.77
F-Score7
WACC8.89%
ROIC/WACC0.73
Cap/Depr(3y)121.2%
Cap/Depr(5y)95.11%
Cap/Sales(3y)3.17%
Cap/Sales(5y)3.13%
Profit Quality(3y)47.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y-13.3%
EPS Next 2Y11.02%
EPS Next 3Y25.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y6.77%
Revenue growth 5Y2.46%
Sales Q2Q%3.35%
Revenue Next Year3.23%
Revenue Next 2Y3.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180.39%
EBIT Next 3Y66.01%
EBIT Next 5YN/A
FCF growth 1Y68.77%
FCF growth 3YN/A
FCF growth 5Y-36.94%
OCF growth 1Y69.53%
OCF growth 3YN/A
OCF growth 5Y1.59%